Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
2.720
-0.280 (-9.33%)
At close: Nov 20, 2024, 4:00 PM
2.700
-0.020 (-0.74%)
Pre-market: Nov 21, 2024, 6:13 AM EST
Affimed Employees
Affimed had 76 employees as of December 31, 2023. The number of employees decreased by 143 or -65.30% compared to the previous year.
Employees
76
Change (1Y)
-143
Growth (1Y)
-65.30%
Revenue / Employee
$82,725
Profits / Employee
-$1,026,832
Market Cap
42.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BGM Group | 298 |
Cytosorbents | 186 |
Prelude Therapeutics | 128 |
CollPlant Biotechnologies | 75 |
Lucid Diagnostics | 70 |
Kronos Bio | 63 |
Protara Therapeutics | 27 |
Milestone Scientific | 17 |
AFMD News
- 6 days ago - Affimed N.V. (AFMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Affimed Reports Third Quarter 2024 Financial Results & Business Update - GlobeNewsWire
- 15 days ago - Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024 - GlobeNewsWire
- 2 months ago - Affimed to Present at the Cantor Global Healthcare Conference 2024 - GlobeNewsWire
- 2 months ago - Affimed N.V. (AFMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Affimed Reports Second Quarter 2024 Financial Results & Business Update - GlobeNewsWire
- 2 months ago - Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts - Seeking Alpha
- 2 months ago - Affimed Appoints Shawn M. Leland as Chief Executive Officer - GlobeNewsWire